As of 2024-12-12, the EV/EBITDA ratio of BioInvent International AB (BINV.ST) is -4.53. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. BINV.ST's latest enterprise value is 1,981.19 mil SEK. BINV.ST's TTM EBITDA according to its financial statements is -437.13 mil SEK. Dividing these 2 quantities gives us the above BINV.ST EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 7.2x - 14.5x | 10.2x |
| Forward P/E multiples | 7.2x - 15.6x | 11.2x |
| Fair Price | (36.92) - (85.94) | (60.27) |
| Upside | -190.6% - -310.9% | -247.9% |
| Date | EV/EBITDA |
| 2024-11-29 | -4.87 |
| 2024-11-28 | -5.05 |
| 2024-11-27 | -5.01 |
| 2024-11-26 | -5.11 |
| 2024-11-25 | -5.28 |
| 2024-11-22 | -5.10 |
| 2024-11-21 | -5.28 |
| 2024-11-20 | -5.27 |
| 2024-11-19 | -5.36 |
| 2024-11-18 | -5.55 |
| 2024-11-15 | -5.81 |
| 2024-11-14 | -6.05 |
| 2024-11-13 | -5.92 |
| 2024-11-12 | -5.56 |
| 2024-11-11 | -5.91 |
| 2024-11-08 | -5.72 |
| 2024-11-07 | -5.31 |
| 2024-11-06 | -5.17 |
| 2024-11-05 | -5.25 |
| 2024-11-04 | -4.95 |
| 2024-11-01 | -4.78 |
| 2024-10-31 | -4.92 |
| 2024-10-30 | -5.04 |
| 2024-10-29 | -5.37 |
| 2024-10-28 | -5.32 |
| 2024-10-25 | -4.98 |
| 2024-10-24 | -4.92 |
| 2024-10-23 | -4.91 |
| 2024-10-22 | -4.90 |
| 2024-10-21 | -4.91 |
| 2024-10-18 | -5.14 |
| 2024-10-17 | -5.05 |
| 2024-10-16 | -5.02 |
| 2024-10-15 | -4.95 |
| 2024-10-14 | -5.01 |
| 2024-10-11 | -5.01 |
| 2024-10-10 | -4.78 |
| 2024-10-09 | -4.90 |
| 2024-10-08 | -4.96 |
| 2024-10-07 | -5.06 |
| 2024-10-04 | -5.09 |
| 2024-10-03 | -5.16 |
| 2024-10-02 | -5.01 |
| 2024-10-01 | -5.16 |
| 2024-09-30 | -5.66 |
| 2024-09-27 | -5.61 |
| 2024-09-26 | -5.60 |
| 2024-09-25 | -5.55 |
| 2024-09-24 | -5.18 |
| 2024-09-23 | -5.02 |